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Abstract : Several studies have reported that the use of a distal protection device decreases
the incidence of slow-flow and/or no-reflow in patients with myocardial infarctions. In the
present study, weinvestigated theinfluenceofa RESCUE/Thrombustersystem and a PercuSurge
GuardWire catheter on coronary microcirculation disorders in patients with acute myocardial
infarction using the natriuretic polypeptide (ANP), the brain natriuretic peptide (BNP), and
99mTc-tetrofosmin myocardial scintigraphy (TF). The group consisted of a77patients with
initial inferior myocardial infarction who had undergone emergency coronary angioplasty.
The patients were randomly divided into : Group D (n=28), in which a direct stent alone was
inserted, Group R/T (n=25), in which a stent was inserted afterRESCUE system ora Thrombuster
system was performed, and Group P (n=24), in which a stent was inserted after thrombus
suction using a PercuSurge GuardWire catheter. Patients with coronary slow-flow/no-reflow
were 3, 2 and 0cases in Group D, Group R / T and Group P, respectively. In the present study,
patients with good-reflow were enrolled in order to investigate the coronary microcirculation
disorder in patients with visually similarcoronary blood flowobtained in coronary angiography
after percutaneous coronary reperfusion therapy. TF myocardial scintigraphy was performed
10±3 days after admission. Bull’s eye images were divided into 8 sections, and each section
was evaluated in 4 grades. The grade of each segment was regarded as the defect score. The
results were compared with the database prepared based on bull’s eye maps from 50 healthy
adults in our hospital, and count areas of－2×SD (standard deviation) or less were calculated
as the extent score (%), reflecting the area in which myocardial blood flow was decreased.
The extent and severity scores in Groups P and R/T were significantly lower than those in
Group D. Coronary angiography at the chronic stage (6 months after surgery) showed the
patency of the responsible vascular lesion in all patients. However, the ANP, BNP, cardiac
index, and pulmonary capillary wedge pressure (PCWP) weresignificantly improved in Groups
R/T and P, compared to Group D (p<0.01). These results suggest that the use of a RESCUE/
Thrombuster system and a PercuSurge GuardWire catheter system in patients with acute
inferior wall infarction improves coronary microcirculation disorders and acute- to chronic-
phase cardiac function. J. Med. Invest. 53 : 167-173, February, 2006
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INTRODUCTION
A thrombus of the coronary artery exists in many
lesions in acute myocardial infarctions, and a throm-
boembolism may occur in a distal area during
treatment of the infarction. A peripheral embolism
or no-reflow phenomena also sometimes occurs(1-
7). Therefore, the presence of a thrombus in the
coronary artery is important with respect to myo-
cardial salvage (8-10). In addition, in many patients
with marked thrombosis, treatment by catheter
intervention is difficult. Several studies have re-
ported that thrombus suction therapy decreases
the incidence of slow flow or no-reflow of the coro-
nary artery (11-13), but the question of whether coro-
nary microcirculation disorders improve after throm-
bus suction therapy in patients in whom good-
reflow of Thrombolysis in Myocardial Infarction
(TIMI) grade 3 has been achieved, using myocar-
dial scintigraphy has not been investigated.
A purpose of the present study is to investigate
the coronary microcirculation disorder in patients
with visually similar coronary blood flow obtained
in coronary angiography after percutaneous coro-
nary reperfusion therapy. Therefore, the issue of
whether thrombus suction therapy improves car-
diac load and coronary microcirculation disorders
in males with acute inferior myocardial infarction
was studied, using the atrial natriuretic polypep-
tide (ANP), the brain natriuretic peptide (BNP),
and nuclear medical parameters, such as the ex-
tent and severity scores of 99mTc-tetrofosmin myo-
cardial scintigraphy (TF).
PATIENTS AND METHODS
1) Patients
The study group consisted of 77males with an
initial acute inferior myocardial infarction (age :
65.5±12.1 years) in whom reperfusion therapy was
successful at the Emergency Center of the Kochi
Red Cross Hospital, Kochi City, Japan, between
September 2000 and December 2004.
We employed the following criteria for acute
myocardial infarction : chest pain persisting for 30
minutes or more ; more than 1-mm increases in
ST at 2 or more leads on standard 12-lead electro-
cardiograms ; a plasma creatinine (CK) level more
than 2 times higher than the normal value ; abnor-
malities in left ventricular wall motion on echocar-
diography ; and an interval of 6 hours or less from
the development of chest pain. Patients who had
undergone fibrinolytic treatment with tissue plas-
minogen activator (t-PA) or urokinase before ad-
mission, those with cardiogenic shock, and those
in whom aspirin or ticlopidine was contraindicated
were excluded from the study. Patients with coro-
nary no-reflow/slow flow and chronic-stage resteno-
sis were excluded. Written informed consent was
obtained from all patients before the study.
Each of the subjects were assigned to one of
three groups by the envelope method with respect
to the procedures for coronary reperfusion ther-
apy : Group D, in which only a direct stent was
used (n=28), Group R/T, in which a stent was in-
serted after thrombus suction using a RESCUE
system (Boston Scientific Scimed, Inc., Maple Grove,
Minnesota, USA) or a Thrombuster system (Kaneka
Medix Corp, Japan)(n=25), or Group P, in which a
stent was inserted after thrombus suction using a
PercuSurge GuardWire catheter (Medtronic AVE,
Santa Rosa, California, USA) (n=24). A MultiLink
Trister stent was used in all patients. Restenosis
was not observed for 6 months after reperfusion,
except in 12 cases.
2) Coronary angiography and percutaneous coro-
nary reperfusion therapy
Prior to coronary reperfusion therapy, 162mg of
aspirin and 200 mg of ticlopidine hydrochloride
were administered, along with an intra-arterial ad-
ministration of heparin at 10,000 units, as antiplate-
let therapy.
Intervention for the coronary artery responsible
for myocardial infarction was performed by punc-
ture of the femoral artery using a 7Fr guiding cathe-
ter. Coronary angiography was performed using a
MODEL CAS 210-A device (TOSHIBA Co., Ltd.,
Japan) and a polygraph (RMC-2000, NIHON
KOHDEN Co., Ltd., Tokyo, Japan).
Three or more cardiologists evaluated the suc-
cess or failure of the acute-stage coronary reperfu-
sion ; in patients in whom the lesion was evaluated
as good-reflow on coronary angiography, reperfu-
sion was considered successful. Similarly, 3 or
more cardiologists evaluated chronic-stage resteno-
sis ; patients with 50% or more stenosis on coro-
nary angiography according to the classification
described by the American Heart Association
were regarded as having restenosis. For the analy-
sis of coronary angiography findings, the diameter
and minimum lumen diameter (MLD) of the infarct-
related artery was measured using the direct cali-
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per method before and after reperfusion therapy
and 6 months after the onset of acute myocardial
infarction.
For antiplatelet therapy after coronary reperfu-
sion therapy, heparin at 20,000units/day was ad-
ministered intra-venously, and aspirin at 162mg/
day and ticlopidine hydrochloride at 200mg/day
were orally administered in each group.
3) Measurement of ANP and BNP
We measured the levels of ANP and BNP imme-
diately after reperfusion and 6months after reper-
fusion. Venous blood through the cubital vein was
collected after the end of percutaneous translumi-
nal coronary angioplasty (PTCA). In the chronic
stage, blood was collected through the cubital vein
after fasting early in the morning on the day be-
fore catheterization. ANP was measured by a ra-
dioimmunoassay (RIA), and BNP by a sandwich
immunoradiometric assay (IRMA).
4) Evaluation of hemodynamics using left ventric-
ulography and a Swan-Gantz catheter
Left ventriculography was performed 1 and 6
months after reperfusion therapy. The left ven-
tricular end-systolic volume index (ESVI), end-
diastolic volume index (EDVI), and ejection frac-
tion (EF) were obtained from 30 -degree right an-
terior oblique left ventriculograms according to
Simpson’s method. Using a Swan-Ganz catheter,
we evaluated the hemodynamics immediately
after reperfusion therapy and 6 months after the
onset of myocardial infarction based on heart rate
(HR), pulmonary capillary wedge pressure (PCWP),
pulmonary arterial pressure (PAP), right ventricu-
lar pressure, right atrial pressure, cardiac output
(CO), cardiac index (CI), and left ventricular end-
diastolic pressure (LVEDP).
5) Myocardial scintigraphy with 99mTc-tetrofosmin
Myocardial scintigraphy with 99mTc-tetrofosmin
was performed on all patients 10±3 days after reper-
fusion therapy, at rest after fasting. Single photon
emission computed tomography (SPECT) was per-
formed 15 minutes after an intravenous injection of
600MBq of 99mTc-tetrofosmin through the cubital
vein. A 3-head rotating gamma camera (GCA, 7200 A,
Toshiba, Japan) with a low-energy all-purpose col-
limator was used for the imaging. The collection
time was 30 seconds per frame, and 360 -degree
data were taken by 72 image stops (5°step ; 24
directions×3 heads) for SPECT imaging. A data
processing super computer (GMS, 5000A, Toshiba,
Japan) was used for analysis of the SPECT data.
From a bull’s eye map, an area counting 2×stan-
dard deviation (SD) or less in comparison to a da-
tabase prepared from 50 normal adults in our hos-
pital (25 men, 25 women) was calculated. The area
of reduced 99mTc-tetrofosmin uptake (extent score)
and severity of deficiency (severity score) were cal-
culated. That is, the extent score (%) and severity
score reflect an area in which myocardial blood
flow is decreased using a bull’s eye map prepared
from SPECT transverse images.
6) Statistical analysis
All values are expressed as the mean±standard
deviation (SD), and statistical analyses were per-
formed using StatView 5.0 software (SAS Institute,
Inc., U.S.A.). The values were compared between
two groups using an unpaired t-test and chi square
test. P<0.05 was regarded as significant.
RESULTS
1) Patient characteristics
The incidence of coronary circulation disorder
in each group was shown in Table 1. Patients with
coronary no-reflow/slow-flow were 3, 2 and 0 cases
in Group D, Group R/T, and Group P, respec-
tively. The incidences of no-reflow/slow-flow in
Group D and Group R/T were significantly higher
than Group P (p<0.05).
Table 2 shows the characteristics of coronary
good-flow patients in the present study. There
were no significant differences in age, number of
affected vessels, presence of concurrent diseases,
such as ischemic heart disease, hypertension, and
diabetes, lipid levels, fasting blood sugar, blood
pressure, combination therapy with ACE inhibi-
tors, interval to obtaining peak CK, post reference
vessel diameter, or post minimal diameter among
Group D, Group R/T, and Group P. However, the
Table 1. Incidence of coronary circulation disorder in each
group
Group D Group R/T Group P
no-reflow/slow flow (cases)
good-reflow (cases)
restenosis 6 months
after reperfusion (cases)
3＊
20
5
2＊
20
3
0
20
4
＊p<0.05 vs Group P
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peak CK levels in Group P and Group R/T were
significantly lower than that in Group D (p<0.01).
2) Comparison of ANP and BNP concentrations on
admission and six months after reperfusion ther-
apy
Table 3 shows the serum levels of ANP and
BNP on admission (at the onset of acute myocar-
dial infarction) and 6 months after reperfusion ther-
apy. There were no significant differences in the
level of ANP on admission among Groups D, R/T,
and P. However, 6 months after admission, the lev-
els of ANP in Group P and Group R/T were sig-
nificantly lower than that in Group D (p<0.05).
The level of BNP on admission in Group R/T
was significantly higher than the values in Groups
D and P (p<0.01). However, 6 months after admis-
sion, the levels of BNP in Groups P and R/T were
significantly lower than that in Group D (p<0.01).
3) Myocardial scintigraphy with 99mTc-tetrofosmin
in Groups D, P, and R/T.
Fig. 1 shows an extent score map for a 64-year-
old subject in Group D. In this patient, reperfusion
therapy with a stent was performed, regarding the
right coronary artery #3 as a responsible coronary
lesion. The area of the defect involved the inferior
wall, the anterior wall septum, and the posterior
lateral wall. His extent score was 49.2, and the se-
verity score was 34.4.
Fig. 2 shows an extent score map for a 72-year-
old subjects in Group P. In this patient, distal pro-
tection with a PercuSurge GuardWire catheter
and reperfusion therapy were performed, regard-
ing the right coronary artery #3 as a responsible
coronary lesion. The defect area involved the infe-
rior wall and the anterior wall septum. His extent
score was 23.5, and the severity score was 12.5.
Fig. 3 shows an extent score map for a 68-year-
old subject in Group R/T. In this patient, distal
protection with the RESCUE system and reperfu-
sion therapy were performed, regarding the right
coronary artery #3 as a responsible coronary
lesion. The defect area involved the inferior wall.
His extent score was 30.6, and his severity score
Table 2. Patient charactaristics
D group R/T group P group
age (yrs)
number of lesion branch
ischemic heart disease
hypertension
smoking
diabetes mellitus
hyperlipidemia
T-cho(mg/dl)
TG(mg/dl)
HDL-cho(mg/dl)
FBS (mg/dl)
ACE-Inhibitor
sBP(mmHg)
dBP(mmHg)
peak CK (IU/l)
time to peak CK (hrs)
Post ref. (acute phase)
Post MLD (acute phase)
66 ± 13
1.8 ± 0.8
4 /20 (20%)
10/20 (50%)
13/20 (65%)
8 /20 (40%)
13/20 (65%)
182±32
139 ± 83
48 ± 8
125 ± 32
15/20 (75%)
115 ± 22
75 ± 15
3151 ± 2467
14 ± 6
3.4 ± 0.4
3.1 ± 0.2
68 ± 9
1.5 ± 0.5
3 /20 (15%)
9 /20 (45%)
10/20 (50%)
9 /20 (45%)
11/20 (55%)
190 ± 49
115 ± 62
53 ± 12
157 ± 84
14/20 (70%)
123 ± 32
72 ± 12
1956 ± 2036＊
12 ± 6
3.3 ± 0.3
3.2 ± 0.2
60 ± 18
1.7 ± 0.8
4 /20 (20%)
10/20 (50%)
11/20 (55%)
9 /20 (45%)
13/20 (65%)
187 ± 30
142 ± 100
44 ± 6
132 ± 55
14/20 (70%)
118 ± 18
76 ± 8
2010 ± 1278＊
13 ± 6
3.6 ± 0.3
3.3 ± 0.3
＊p<0.01 difference between D group.
T-cho, total cholesterol ; T-G, triglyceride ; HDL-cho, high-density lipoprotein cholesterol ; FBS, fasting blood sugar ; ACE, an-
giotensin converting enzyme ; sBP, systolic blood pressure ; dBP, diastolic blood pressure ; CK, creatine kinase ; post ref., post ref-
erence vessel diameter ; post MLD, post minimal lumen diameter
Table 3. Serum levels of ANP and BNP on admission and 6
months after reperfusion
D group R/T group P group
ANP (pg/ml)
admission
6 months
85±72
53±30
86±118
25±15＊＊
78±64
30±28＊＊
BNP (pg/ml)
admission
6 months
58±59
133±127
121±191＊
62±50＊
65±95
82±76＊
*p<0.01, **p<0.05 difference between D group.
ANP, A type natriuretic peptide; BNP, B type natriuretic peptide
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was 15.6.
4) Comparison of scintigraphic scores among Groups
D, P, and R/T.
As shown in Table 4, the extent and severity
scores were compared among Groups D, P, and R/
T. The extent and severity scores in Groups P and
R/T were significantly lower than those in Group D.
5) Pressure study and ejection fraction in the chronic
stage
Table 5 shows the pressure study and EF on heart
catheterization 6 months after the onset of myo-
cardial infarction. No significant differences were
found in PCWP, mean PAP, CI, EDVI, or EF among
the 3 groups.
DISCUSSION
It has been reported that thrombus suction ther-
apy decreases the incidence of slow flow or no-
reflow during coronary artery perfusion therapy in
patients with acute myocardial infarctions (14).
However, the question of whether thrombus suc-
tion therapy improves coronary microcirculation
disorders by myocardial scintigraphy in patients in
whom good-reflow is achieved after thrombus suc-
tion therapy has not been investigated. In the pre-
sent study, there was no difference between
Groups D and R/T in the incidence of slow-flow/
no-reflow, but the improvement of microcircula-
tion at the chronic stage in good-reflow patient of
Group R/T was more frequent than that of Group
D. Moreover, thrombus suction therapy with a
RESCUE system, a Thrombuster system, or a
PercuSurge GuardWire catheter significantly im-
proved ANP, BNP, and peak CK levels and myo-
cardial scintigraphic parameters in comparison to
direct stenting, indicating the usefulness of these
therapies on myocardial coronary microcirculation
disorders.
The use of direct stent therapy has decreased in
treatment of acute myocardinal infarctions. How-
ever, it continues to be performed in some hospi-
Fig. 1． Extent score map in a 64-year-old man in Group D.
Fig. 2． Extent score map in a 72-year-old man in Group P.
Fig. 3． Extent score map in a 68-year-old man in Group R/T.
Table 4. Comparison of scintiphotogrhic scores among D, R/T
and P groups
D group R/T group P group
extent score
severity score
42±9
36±7
30±6＊
25±3＊
31±5＊＊
26±4＊
*p<0.01, **p<0.05 difference between D group.
Table 5. Pressure study and ejection fraction on heart cath-
erization 6 months after the on set of myocardial infarction
D grou P group R group
PCW(mmHg)
(6 months)
mPA(mmHg)
(6 months)
CI(l/min/ml)
(6 months)
EDVI(ml/m2)
(6 months)
EF(%)
(6 months)
18±7
38±12
3.0±1.0
77±32
50±8
16±3
34±2
2.9±0.8
82±18
54±11
18±8
36±16
2.6±0.6
80±20
52±12
PCWP, pulmonary capillary wedge pressure ; mPA, mean pul-
monary artery pressure;C.I., cardiac index;EDVI, end-diastolic
volume index ; EF, ejection fruction
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tals. We previously reported differences in cardiac
function of the chronic stage between POBA and
stent therapy in acute myocardial infarctions (15).
Therefore, patients who had received direct stent
therapy were enrolled in this study in order to
standardize the control subjects.
For percutaneous transluminal coronary an-
gioplasty for acute myocardial infarction, TIMI
grade 3 blood flow in the early stage is required,
for to a good prognosis (16-18). However, coro-
nary reperfusion at the site of the lesion, where
many thrombi are present, causes peripheral em-
bolism related to rupture of the thrombus or the
no-reflow phenomena (19). According to previous
reports, the combination of distal protection with a
balloon and thrombus suction therapy in patients
with acute myocardial infarction resulted in high-
grade TIMI blood flow, suggesting the usefulness
of this combination therapy in marked thrombotic
lesions (11-13).
In the present study, myocardial scintigraphic
findings as well as the ANP and BNP levels were
significantly improved in patients in whom a Per-
cuSurge GuardWire catheter or a RESCUE system/
Thrombuster system was employed as a protec-
tive device for preventing peripheral embolisms,
even among patients with good-reflow. Thus,
among patients in whom direct stent therapy with-
out distal protection achieved TIMI grade 3 blood
flow, and coronary angiography confirmed good
circulatory reconstruction, a significant improve-
ment was achieved in patients in whom thrombus
suction therapy with a RESCUE system/Throm-
buster system or a PercuSurge GuardWire cathe-
ter was performed, suggesting that the combina-
tion of distal protection with a balloon and throm-
bus suction therapy is effective regardless of the
presence of a visually recognizable thrombus.
However, there were no significant differences
in cardiac function (EF) among Groups D, R/T,
and P 6 months after the onset of the myocardial
infarction. Possible reasons for the discrepancy
between EF and ANP/BNP levels are as follows.
First, EF values were almost normal or slightly de-
creased in all patients because of successful reper-
fusion therapy, second, ANP and BNP are more
sensitive markers of cardiac function than EF,
third, ANP and BNP affect the left ventricular dia-
stolic function.
Significant changes were found in myocardial
scintigraphic findings and ANP, BNP levels in pa-
tients in whom visually high-grade TIMI blood
flow was achieved. The following mechanism is as-
sumed. Platelets are usually activated after percu-
taneous transluminal coronary angioplasty (20).
However, the removal of a peripheral microthrom-
bus using a distal protection device inhibits plate-
let activation enhancement after percutaneous
transluminal coronary angioplasty.
In the present study, we investigated only male
with inferior myocardial infarction, because myo-
cardial infarction is less frequent in woman, and
because most women with a myocardial infarction
are older and suffer a severe infarction. Because of
these gender-related differences, the study was
limited to males. Furthermore, we focused on
acute inferior myocardial infarction, because a
thrombosis is involved in right coronary infarction
in many cases (21). In the future, left coronary le-
sions should be investigated.
In conclusion, it has been recently reported that
the use of drug-eluting stents is associated with the
reduction of coronary artery restenosis compared
with the bare thin-strut stent (22-24). These re-
sults suggest that thrombus suction therapy prior
to stenting may improve coronary microcircula-
tion disorders in the acute to chronic stages in
males with inferior myocardial infarction.
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